New drugs using only a computer, the internet and free online data

May 6, 2016 by David Glance, The Conversation
Garage Startup. Credit: LinkedIn

Pharmaceutical companies typically develop new drugs with thousands of staff and budgets that run into the billions of dollars. One estimate puts the cost of bringing a new drug to market at $2.6 billion with others suggesting that it could be double that cost at $5 billion.

One man, Professor Atul Butte director of the University of California Institute of Computational Health Sciences, believes that like other Silicon Valley startups, almost anyone can bring a to market from their garage with just a computer, the internet, and freely available data.

In a talk given at the Science on the Swan conference held in Perth this week, Professor Butte outlined the process for an audience of local and international scientists and medics.

The starting point is the genetic data from thousands of studies on humans, mice and other animals, that is now freely available on sites from the National Institute of Health and the European Molecular Biology Laboratory. The proliferation of from experiments has been driven by the ever decreasing cost of sequencing genetic information using gene chip technologies.

Professor Butte, students, and research staff have found a range of different ways of using this data to look for new drugs. In one approach, they have constructed a map of how the of people with particular diseases are related to each other. In particular, to look for diseases with very similar genetic profiles. Having done that, they noticed that the genetic profile of people with heart conditions were very closely related to that of the much rarer condition of muscular dystrophy. What this potentially suggested was that drugs that work for one condition could potentially work in the other. This process of discovering other uses of drugs, called "drug repositioning", is not new. Drugs like Viagra were originally used for treatment of cardiovascular conditions. The difference is that Viagra's repositioned use resulted from the observation of side-effects in patients taking the drug for its original intended purpose.

Professor Butte on the other hand is using "Big Data" and computers to show that given the close relationship in the genetic profile of two diseases, the potential cross-over effect of drugs working for one condition working in another.

Still in the garage, the next step from discovering a potential drug is to test if it actually works in an experimental setting on animals. Here again, Professor Butte has turned to the internet and sites like Assay Depot. This is a site, structured like Amazon, from which a researcher can order an experiment to be carried out to test a drug on a range of animal models. It is literally a case of choosing the experiment type you want, adding it to a shopping cart, paying by credit card and getting the experimental results mailed back in a few weeks time. "Shoppers" are given the choice of laboratory they want to use, including a choice of which country the lab is based.

Once a new use for a drug has been shown to work in an animal model, the next step would be to test the drug in humans, get approval for the use of the drug for that condition and then finally take the drug to market.

In California where Professor Butte works, this has involved spinning out companies with money from investors, a process that he and his students have done after the discovery of new uses for several drugs.

As with cloud computing and cloud labour, "cloud research" works because services can be sourced inexpensively from laboratories that have expertise in particular areas. In one case, Professor Butte related a story of needing to see if a drug would cure inflammatory bowel diseases in rats which involved performing colonoscopies on the animals. This expertise and equipment was available somewhere in the world, made accessible through a simple online shopping interface.

The entire process outlined for this type of drug discovery, testing and commercialisation, radically changes the nature of how quickly and cheaply, can be brought to market to treat conditions for which there would still be few options.

None of this would be possible without the sharing of data and it highlights how the growth of availability of open research data will be able to fuel a range of uses that would not have been foreseen when the individual experiments were being carried out.

Explore further: Computational method predicts new uses for existing medicines

Related Stories

Computational method predicts new uses for existing medicines

August 17, 2011
For the first time ever, scientists are using computers and genomic information to predict new uses for existing medicines.

FDA panel backs lower-cost version of J&J's top-selling drug

February 10, 2016
Federal health advisers have endorsed a lower-cost version of Johnson & Johnson's blockbuster drug Remicade, a pricey biotech medicine used to treat a number of inflammatory diseases.

Modifying an obesity drug could reduce side effects like anxiety and depression

April 28, 2016
A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published ...

Drug development crisis linked to bad technology choices, experts argue

February 15, 2016
The search for new medicines is becoming unsustainably expensive despite huge technological advances because researchers are using the wrong methods, experts say.

Scientists find new uses for existing drugs by mining gene-activity data banks

August 17, 2011
Researchers at the Stanford University School of Medicine have paired up medicines and maladies with help from a molecular "Match.com." When the scientists applied an "opposites attract" algorithm to publicly available databases, ...

FDA-approved antidepressant may combat deadly form of lung cancer, study finds

September 27, 2013
A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study from researchers at the Stanford University School of Medicine.

Recommended for you

Opioid addiction treatment behind bars reduced post-incarceration overdose deaths in RI

February 14, 2018
A treatment program for opioid addiction launched by the Rhode Island Department of Corrections was associated with a significant drop in post-incarceration drug overdose deaths and contributed to an overall drop in overdose ...

Heroin vaccine blocks lethal overdose

February 14, 2018
Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug. Their research, published ...

Study shows NIH spent >$100 billion on basic science for new medicines

February 12, 2018
Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study by Bentley University.

Opioid use increases risk of serious infections

February 12, 2018
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.

Placebo pills prescribed honestly help cancer survivors manage symptoms

February 9, 2018
Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers at the University of Alabama at Birmingham and Harvard Medical School have ...

Multinational companies continue to produce unregulated antibiotics in India

February 5, 2018
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.